There is a known association between elevated lipids and poor outcome in non-MYC/N driven brain tumors [52], hence ongoing investigation of underlying lipid metabolism and the relationship to other metabolic pathways in cancer is essential. The gene discussed is MYC; the disease is brain neoplasm.